Support for developing biological therapies for brain disorders
Official title: REGULATORY AFFAIRS CONSULTANT SUPPORT SERVICES
NIH-11188937 · Data updated 2026-11-12
This study is all about helping to create new biologic treatments for brain and nervous system disorders, making sure they are safe and effective so that patients can have better options for their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project start | September 19, 2023 |
| Project end | September 18, 2025 |
| Funding year | 2024 |
| Award (this year) | $3,820 |
| NIH project number | 75N95023P00850-P00001-0-1 |
| Project ID | NIH-11188937 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from various central nervous system disorders who may benefit from new biologic therapies.
✕Less likely to help
Patients with CNS disorders that are not amenable to biologic therapies may not receive benefit from this research.
What this research studies
This research focuses on providing regulatory affairs support to facilitate the development of biologic therapies aimed at treating central nervous system disorders. It involves navigating the complex regulatory landscape to ensure that new biologic treatments are developed safely and effectively. Patients may benefit from this work as it aims to bring innovative therapies to market that could improve outcomes for those with CNS diseases.
Why it matters
Potential benefit: If successful, this research could lead to the development of new biologic therapies that improve treatment options for patients with central nervous system disorders.
How similar studies have gone: While this approach is essential for the development of biologic therapies, similar regulatory support efforts have shown success in advancing treatments for other medical conditions.
Where this research is happening
Waltham, United States
Researchers
- Principal investigator: Bradel, Roman
- Study coordinator: Bradel, Roman
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.